Scancell SCNLF Stock
Scancell Price Chart
Scancell SCNLF Financial and Trading Overview
| Scancell stock price | 0.28 USD |
| Previous Close | 0.28 USD |
| Open | 0.31 USD |
| Bid | 0.25 USD x 250000 |
| Ask | 0.3 USD x 250000 |
| Day's Range | 0.31 - 0.31 USD |
| 52 Week Range | 0.12 - 0.33 USD |
| Volume | 2.5K USD |
| Avg. Volume | 1.76K USD |
| Market Cap | 353.94M USD |
| Beta (5Y Monthly) | 0.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SCNLF Valuation Measures
| Enterprise Value | 294.23M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 75.13012 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 62.455 |
| Enterprise Value/EBITDA | -22.697 |
Trading Information
Scancell Stock Price History
| Beta (5Y Monthly) | 0.71 |
| 52-Week Change | 132.08% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.33 USD |
| 52 Week Low | 0.12 USD |
| 50-Day Moving Average | 0.24 USD |
| 200-Day Moving Average | 0.17 USD |
SCNLF Share Statistics
| Avg. Volume (3 month) | 1.76K USD |
| Avg. Daily Volume (10-Days) | 667 USD |
| Shares Outstanding | 1.04B |
| Float | 582.62M |
| Short Ratio | N/A |
| % Held by Insiders | 3.65% |
| % Held by Institutions | 44.58% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2025 |
| Most Recent Quarter (mrq) | October 31, 2025 |
| Next Fiscal Year End | April 30, 2026 |
Profitability
| Profit Margin | -116.98% |
| Operating Margin (ttm) | -283.33% |
| Gross Margin | 94.94% |
| EBITDA Margin | -275.16% |
Management Effectiveness
| Return on Assets (ttm) | -52.16% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 4.71M USD |
| Revenue Per Share (ttm) | 0.005 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 4.47M USD |
| EBITDA | -12963000 USD |
| Net Income Avi to Common (ttm) | -5511000 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.57M USD |
| Total Cash Per Share (mrq) | 0.008 USD |
| Total Debt (mrq) | 16.18M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.559 |
| Book Value Per Share (mrq) | -0.0105864 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8649000 USD |
| Levered Free Cash Flow (ttm) | -17118624 USD |
Profile of Scancell
| Country | United States |
| State | N/A |
| City | Oxford |
| Address | Bellhouse Building |
| ZIP | OX4 4GD |
| Phone | 44 18 6558 2066 |
| Website | https://www.scancell.co.uk |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 60 |
Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom.
Q&A For Scancell Stock
What is a current SCNLF stock price?
Scancell SCNLF stock price today per share is 0.28 USD.
How to purchase Scancell stock?
You can buy SCNLF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Scancell?
The stock symbol or ticker of Scancell is SCNLF.
Which industry does the Scancell company belong to?
The Scancell industry is Biotechnology.
How many shares does Scancell have in circulation?
The max supply of Scancell shares is 1.13B.
What is Scancell Price to Earnings Ratio (PE Ratio)?
Scancell PE Ratio is now.
What was Scancell earnings per share over the trailing 12 months (TTM)?
Scancell EPS is -0.01 USD over the trailing 12 months.
Which sector does the Scancell company belong to?
The Scancell sector is Healthcare.